company background image
600329 logo

Tianjin Pharmaceutical Da Ren Tang Group SHSE:600329 Stock Report

Last Price

CN¥35.47

Market Cap

CN¥24.6b

7D

-5.9%

1Y

-22.1%

Updated

13 Jun, 2024

Data

Company Financials +

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

SHSE:600329 Stock Report

Market Cap: CN¥24.6b

600329 Stock Overview

Produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China.

600329 fundamental analysis
Snowflake Score
Valuation1/6
Future Growth2/6
Past Performance2/6
Financial Health5/6
Dividends3/6

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Tianjin Pharmaceutical Da Ren Tang Group
Historical stock prices
Current Share PriceCN¥35.47
52 Week HighCN¥46.95
52 Week LowCN¥23.40
Beta0.68
1 Month Change-4.91%
3 Month Change18.79%
1 Year Change-22.10%
3 Year Change53.35%
5 Year Change150.14%
Change since IPO153.36%

Recent News & Updates

Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Apr 18
Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Recent updates

Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Apr 18
Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Mar 18
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Shareholder Returns

600329CN PharmaceuticalsCN Market
7D-5.9%-0.8%-0.9%
1Y-22.1%-9.9%-14.4%

Return vs Industry: 600329 underperformed the CN Pharmaceuticals industry which returned -9.9% over the past year.

Return vs Market: 600329 underperformed the CN Market which returned -14.4% over the past year.

Price Volatility

Is 600329's price volatile compared to industry and market?
600329 volatility
600329 Average Weekly Movement4.6%
Pharmaceuticals Industry Average Movement5.5%
Market Average Movement6.7%
10% most volatile stocks in CN Market10.1%
10% least volatile stocks in CN Market4.1%

Stable Share Price: 600329 has not had significant price volatility in the past 3 months.

Volatility Over Time: 600329's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19814,619Lei Wangwww.jydrt.com.cn

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited, together with its subsidiaries, produces and sells traditional Chinese medicine, western medicine, and other products primarily in the People’s Republic of China. The company is also involved in the manufacture and sale of Chinese and western pharmaceutical and biological products; and biochemical pharmaceutical products, as well as wholesale and retail sale of medicines. Its products include Suxiao Jiuxin Pills, Jingwanhong Ointment, Biqi Capsules, Shunaoxin Dropping Pills, Zilongjin Tablets, Qingfei Xiaoyan Pills, Huoxiangzhengqi Soft Capsules, Tongmai Yangxin Pills, Weichangan Pills, Qingyan Dropping Pills, Haima Bushen Pills, Angong Niuhuang Pills, Niuhuang Qingxin Pills, Qinggong Shoutao Pills, etc. The company also engages in pharmaceutical commercial logistic services; pharmaceuticals retail; chemical raw materials and preparations; and biomedicine.

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited Fundamentals Summary

How do Tianjin Pharmaceutical Da Ren Tang Group's earnings and revenue compare to its market cap?
600329 fundamental statistics
Market capCN¥24.60b
Earnings (TTM)CN¥973.25m
Revenue (TTM)CN¥8.15b

28.1x

P/E Ratio

3.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
600329 income statement (TTM)
RevenueCN¥8.15b
Cost of RevenueCN¥4.54b
Gross ProfitCN¥3.61b
Other ExpensesCN¥2.64b
EarningsCN¥973.25m

Last Reported Earnings

Mar 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)1.26
Gross Margin44.33%
Net Profit Margin11.94%
Debt/Equity Ratio8.9%

How did 600329 perform over the long term?

See historical performance and comparison

Dividends

3.6%

Current Dividend Yield

102%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.